BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 36437939)

  • 1. Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06).
    Kim JW; Lee HJ; Lee JY; Park SR; Kim YJ; Hwang IG; Kyun Bae W; Byun JH; Kim JS; Kang EJ; Lee J; Shin SJ; Chang WJ; Kim EO; Sa JK; Park KH
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38485184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation.
    Liu X; Liu H; Wang L; Han Y; Kong L; Zhang X
    Diagn Pathol; 2024 Feb; 19(1):29. PubMed ID: 38341587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.
    Tufano RP; Teixeira GV; Bishop J; Carson KA; Xing M
    Medicine (Baltimore); 2012 Sep; 91(5):274-286. PubMed ID: 22932786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer.
    Jin Y; Qiu X; He Z; Wang J; Sa R; Chen L
    Front Genet; 2022; 13():966365. PubMed ID: 36437939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Papillary Thyroid Carcinoma.
    Lin X; Zhang J; Zhao RH; Zhang WJ; Wu JF; Xue G
    J Cancer; 2022; 13(5):1652-1663. PubMed ID: 35371313
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune profiling identifies CD8
    Chen Z; Guo ML; Li YY; Yan K; Li L; Shen F; Guan H; Liu QZ; Xu B; Lian ZX
    Front Immunol; 2022; 13():894919. PubMed ID: 36420264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma.
    Lin X; Wang ZY; Xue G; Qin XJ; Wu JF; Zhang G
    J Cancer; 2021; 12(13):3997-4010. PubMed ID: 34093805
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of ANGPTL2 and its impact on papillary thyroid cancer.
    Yang L; Sun R; Wang Y; Fu Y; Zhang Y; Zheng Z; Ji Z; Zhao D
    Cancer Cell Int; 2019; 19():204. PubMed ID: 31384179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSG7 indicates that age at diagnosis is associated with papillary thyroid carcinoma: A study based on the cancer genome atlas data.
    Tian T; Zhang Z; Chen T
    Front Genet; 2022; 13():952981. PubMed ID: 36276966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized Transcriptional Signature for Evaluation of MEK/ERK Pathway Baseline Activity and Long-Term Modulations in Ovarian Cancer.
    Chesnokov MS; Yadav A; Chefetz I
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance in targeted cancer therapies with RAF inhibitors.
    Degirmenci U; Yap J; Sim YRM; Qin S; Hu J
    Cancer Drug Resist; 2021; 4(3):665-683. PubMed ID: 35582307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer statistics in China and United States, 2022: profiles, trends, and determinants.
    Xia C; Dong X; Li H; Cao M; Sun D; He S; Yang F; Yan X; Zhang S; Li N; Chen W
    Chin Med J (Engl); 2022 Feb; 135(5):584-590. PubMed ID: 35143424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HER2 therapy in metastatic breast cancer: many choices and future directions.
    Wynn CS; Tang SC
    Cancer Metastasis Rev; 2022 Mar; 41(1):193-209. PubMed ID: 35142964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven Genes Associated With Lymphatic Metastasis in Thyroid Cancer That Is Linked to Tumor Immune Cell Infiltration.
    Wu L; Zhou Y; Guan Y; Xiao R; Cai J; Chen W; Zheng M; Sun K; Chen C; Huang G; Zhang X; Qian Z; Shen S
    Front Oncol; 2021; 11():756246. PubMed ID: 35141140
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.